Professor Kappetein sits down with Mr Dincer Aktuerk of Barts Heart Center in London, United Kingdom and Professor Robert Klautz of Leiden University Medical Center, Netherlands to discuss the clinical data from the PERIGON Study. This discussion covers a variety of topics including the importance of data when treating patients, with a focus on lifetime management and durability of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) surgeries.1
Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.
See Avalus™ Bioprosthesis risk information: https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/heart-valves/tissue-valves-conduits/avalus-bioprosthesis.html?sheet=open
Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.
Segment 3 focuses on discussing guidelines and advantages of trails
Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.
Segment 2 focuses on patient factors, best practices and strategies and valve size
Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.
Segment 1 focuses on growing popularity and lifetime management and risks
Penditure Exclusion System: Left Atrial Appendage Management
Host: Pieter Kappetein
Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia
Segment 2: Robotic Closure, Appendage management for all AFib patients
Penditure Exclusion System: Left Atrial Appendage Management
Host: Pieter Kappetein
Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia
Segment 1: Candidates, Circumstances, Clip Placement
Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.
Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.
Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.
Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.
Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.
Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.
Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.
Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.
